In the ongoing saga of whether Merck will acquire formidable biotech Seagen, the companies have scheduled a meeting this week, sources told The Wall Street Journal on Thursday.
Others are eyeing the Seattle firm, people have told the WSJ, but none of those companies have been identified.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,